Literature DB >> 8018677

Diversity of T-cell antigen receptor V beta gene utilization in advanced human atheroma.

S J Swanson1, A Rosenzweig, J G Seidman, P Libby.   

Abstract

Human atheromata contain T lymphocytes, but knowledge of the function and receptor specificity of these cells is limited. Immunohistochemical studies have established that T cells in advanced human carotid plaques express predominantly the alpha/beta form of the T-cell receptor (TCR). We then compared the use of variable region genes of the beta-chain (V beta) of the TCR for antigen by analysis of 14 carotid plaques and peripheral blood samples obtained at carotid endarterectomy. We used a direct approach that avoids isolation and culture of T cells. RNA extracted from lesions and peripheral blood mononuclear cells was reverse transcribed and amplified by polymerase chain reaction (PCR) to determine rearrangements of 18 V beta sequences. PCR products were visualized on Southern blots using a probe internal to the PCR primers. Input cDNA from lesions and peripheral blood was adjusted to yield equivalent signals for a conserved region of the TCR beta-chain to permit comparisons. As expected, utilization of TCR V beta genes in peripheral blood cells was nonselective: an average of 17 of 18 V beta regions yielded signals (n = 14). Frequency of variable-region gene usage in lesions and blood was highly concordant: of 252 sequences tested (14 samples, 18 sequences per sample), 240 were identified in peripheral blood versus 207 in plaques. V beta genes 10 and 11 were not expressed in plaques, a significant difference when compared with peripheral blood (P = .0001 by chi 2). However, the remaining 16 genes showed no significant differences. This analysis indicates that T cells generally express a diverse pattern of V beta genes within complex human atheroma.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8018677     DOI: 10.1161/01.atv.14.7.1210

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  7 in total

1.  The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice.

Authors:  A Daugherty; E Puré; D Delfel-Butteiger; S Chen; J Leferovich; S E Roselaar; D J Rader
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

Review 2.  Innate and adaptive immunity: the understudied driving force of heart valve disease.

Authors:  Francesca Bartoli-Leonard; Jonas Zimmer; Elena Aikawa
Journal:  Cardiovasc Res       Date:  2021-11-22       Impact factor: 10.787

3.  Interferon-γ Released by Activated CD8+ T Lymphocytes Impairs the Calcium Resorption Potential of Osteoclasts in Calcified Human Aortic Valves.

Authors:  Edit Nagy; Yang Lei; Eduardo Martínez-Martínez; Simon C Body; Florian Schlotter; Michael Creager; Alexander Assmann; Kamal Khabbaz; Peter Libby; Göran K Hansson; Elena Aikawa
Journal:  Am J Pathol       Date:  2017-04-19       Impact factor: 4.307

Review 4.  Molecular imaging of atherosclerosis.

Authors:  Mark P S Dunphy; H William Strauss
Journal:  Curr Cardiol Rep       Date:  2008-03       Impact factor: 2.931

5.  Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques.

Authors:  M D Rekhter; D Gordon
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

Review 6.  Estimating T-cell repertoire diversity: limitations of classical estimators and a new approach.

Authors:  Daniel J Laydon; Charles R M Bangham; Becca Asquith
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-08-19       Impact factor: 6.237

7.  Restricted T-Cell Repertoire in the Epicardial Adipose Tissue of Non-ST Segment Elevation Myocardial Infarction Patients.

Authors:  Daniela Pedicino; Anna Severino; Gabriele Di Sante; Maria Cristina De Rosa; Davide Pirolli; Ramona Vinci; Vincenzo Pazzano; Ada F Giglio; Francesco Trotta; Giulio Russo; Aureliano Ruggio; Eugenia Pisano; Alessia d'Aiello; Francesco Canonico; Pellegrino Ciampi; Domenico Cianflone; Lorenzo Cianfanelli; Maria Chiara Grimaldi; Simone Filomia; Nicola Luciani; Franco Glieca; Piergiorgio Bruno; Massimo Massetti; Francesco Ria; Filippo Crea; Giovanna Liuzzo
Journal:  Front Immunol       Date:  2022-07-08       Impact factor: 8.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.